期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 53, 期 19, 页码 6986-6995出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm1006269
关键词
-
We report the discovery of a new family of alpha(2) adrenergic receptor antagonists derived from atipamezole. Affinities of the compounds at human alpha(2) in alpha(1h) receptors as well as their functional activities at h alpha(2A) receptors were determined in competition binding and G-protein activation assays, respectively. Central antagonist activities were confirmed in mice alter oral administration. Further studies on a selected example: (+)-4-(1a,6-dihydro-1 H-cyclopropa]inden-6a-yl)-1H-imidazole, (+)-1 (F 148055), were undertaken to probe the potential of the series. On the one hand, (+)-1 increased the release of noradrenaline in mouse frontal cortex following acute systemic administration, the magnitude of this effect being much larger than that obtained with reference agents. On the other, (+1)-1 produced minimal cardiovascular effects in intact, anesthetized rat, a surprising outcome that might be explained by its differential action at peripheral and central alpha(2) receptors. A strategy for improving the therapeutic window of alpha(2) antagonists is put forward.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据